Innovation Pharmaceuticals Inc (IPIX)

[warrenthomas4001]

Someone play devil’s advocate here.. Surely someone in Trump’s circle is aware of Brilacidin and the Rem/Brilacidin combo results. What is conceivably being argued against advancing Brilacidin? “Oh it’s only in early stage clinicals, Rem was much further ahead”, “Safety and tolerability are suspiciously too good, ergo: it can’t be efficacious”, “the compounder needs 6-8 weeks to deliver”.. what is it? I know we’re in some Tower of Babel bizarro world, but some things are so intuitive, you’d think they’d break out on their merit.